a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need.
Industry Biotechnology
A.I.dvisor indicates that over the last year, ONCT has been loosely correlated with FULC. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCT jumps, then FULC could also see price increases.
| Ticker / NAME | Correlation To ONCT | 1D Price Change % | ||
|---|---|---|---|---|
| ONCT | 100% | N/A | ||
| FULC - ONCT | 53% Loosely correlated | -2.93% | ||
| SAVA - ONCT | 28% Poorly correlated | -0.92% | ||
| KURA - ONCT | 26% Poorly correlated | -0.83% | ||
| HOOK - ONCT | 26% Poorly correlated | +0.52% | ||
| MRNA - ONCT | 25% Poorly correlated | -2.90% | ||
More | ||||